gvtcx

National Microbiology Framework - Lot 1: Diagnostic Goods and Services

Public Health England Published 5 Nov 2020 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£3,000,000,000
Statuscomplete
Category (CPV) 33000000 +2 more
Deadline7 Dec 2020
Contract start9 Apr 2021
Contract end8 Apr 2023
Procedureopen
SME suitableYes
OCIDocds-b5fd17-f7d14908-7da1-4faa-8801-324f837a758e

Awards (224)

This procurement was awarded to 127 suppliers. Values shown are per-award; the notice total is £3,000,000,000.

SupplierValueDateStatus
Abbott Laboratories Limited shared £3,000,000,000 8 Mar 2021 active
Abbott Laboratories Limited shared · · active
Abbott Rapid Diagnostics Limited shared £3,000,000,000 8 Mar 2021 active
Abbott Rapid Diagnostics Limited shared · · active
AB Molecular Limited shared £3,000,000,000 8 Mar 2021 active
AB Molecular Limited shared · · active
AB Scientific Limited shared £3,000,000,000 8 Mar 2021 active
AB Scientific Limited shared · · active
AESKU.UK Ltd shared £3,000,000,000 8 Mar 2021 active
AESKU.UK Ltd shared · · active
Agena Bioscience GmbH shared £3,000,000,000 8 Mar 2021 active
Agena Bioscience GmbH shared · · active
Alphabiolaboratories Analytical Ltd shared £3,000,000,000 8 Mar 2021 active
Alphabiolaboratories Analytical Ltd (T/A AlphaBiolabs) shared · · active
Alpha Laboratories Ltd shared £3,000,000,000 8 Mar 2021 active
Alpha Laboratories Ltd shared · · active
Altona Diagnostics UK Ltd shared £3,000,000,000 8 Mar 2021 active
Altona Diagnostics UK Ltd shared · · active
A.Menarini Diagnostics Ltd shared £3,000,000,000 8 Mar 2021 active
A.Menarini Diagnostics Ltd shared · · active
Appleton Woods Ltd shared £3,000,000,000 8 Mar 2021 active
Appleton Woods Ltd shared · · active
AusDiagnostics UK Limited shared · · active
AusDiagnostics UK Ltd shared £3,000,000,000 8 Mar 2021 active
Beckman Coulter United Kingdom Limited shared £3,000,000,000 8 Mar 2021 active
Beckman Coulter United Kingdom Limited shared · · active
Becton, Dickinson U.K. Limited shared £3,000,000,000 8 Mar 2021 active
Becton, Dickinson U.K. Limited shared · · active
BGI Genomics UK CO LTD shared £3,000,000,000 8 Mar 2021 active
BGI Genomics UK CO LTD shared · · active
BioConnections Ltd shared £3,000,000,000 8 Mar 2021 active
BioConnections Ltd shared · · active
bioMérieux UK Limited shared £3,000,000,000 8 Mar 2021 active
bioMérieux UK Limited shared · · active
Bio-Rad Laboratories Limited shared £3,000,000,000 8 Mar 2021 active
Bio-Rad Laboratories Limited shared · · active
Bioserv UK shared · · active
BioservUK shared £3,000,000,000 8 Mar 2021 active
BioSure (UK) Ltd shared £3,000,000,000 8 Mar 2021 active
BioSure (UK) Ltd shared · · active
Bruker UK Limited shared · · active
Bruker UK Ltd shared £3,000,000,000 8 Mar 2021 active
Cambridge Bioscience Limited shared £3,000,000,000 8 Mar 2021 active
Cambridge Bioscience Limited shared · · active
Cambridge Life Sciences Limited shared £3,000,000,000 8 Mar 2021 active
Cambridge Life Sciences Limited shared · · active
Cepheid UK Ltd shared £3,000,000,000 8 Mar 2021 active
Cepheid UK Ltd shared · · active
Cerescom Ltd and Cargo Services Far East shared £3,000,000,000 8 Mar 2021 active
Cerescom Ltd (in partnership with Cargo Services Far East Limited) shared · · active
Chase Madison shared £3,000,000,000 8 Mar 2021 active
Chase Madison shared · · active
Chirus Limited shared £3,000,000,000 8 Mar 2021 active
Chirus Limited shared · · active
Connect2pharma Ltd shared £3,000,000,000 8 Mar 2021 active
Connect2pharma Ltd shared · · active
DiaSorin Ltd shared £3,000,000,000 8 Mar 2021 active
DiaSorin Ltd shared · · active
DnaNudge Limited shared £3,000,000,000 8 Mar 2021 active
DnaNudge Limited shared · · active
Don Whitley Scientific Ltd shared £3,000,000,000 8 Mar 2021 active
Don Whitley Scientific Ltd shared · · active
ELItech UK Limited shared £3,000,000,000 8 Mar 2021 active
ELItech UK Limited shared · · active
Eurofins Biomnis UK Ltd shared £3,000,000,000 8 Mar 2021 active
Eurofins Biomnis UK Ltd shared · · active
Euroimmun UK Ltd shared £3,000,000,000 8 Mar 2021 active
Euroimmun UK Ltd shared · · active
Europlaz Technologies Limited shared £3,000,000,000 8 Mar 2021 active
Europlaz Technologies Limited shared · · active
Excalibur Healthcare Services Ltd shared £3,000,000,000 8 Mar 2021 active
Excalibur Healthcare Services Ltd shared · · active
Genedrive Diagnostics Ltd shared £3,000,000,000 8 Mar 2021 active
Genedrive Diagnostics Ltd shared · · active
GeneFirst Limited shared £3,000,000,000 8 Mar 2021 active
GeneFirst Limited shared · · active
Genetic Signatures UK Ltd shared £3,000,000,000 8 Mar 2021 active
Genetic Signatures UK Ltd shared · · active
Greiner Bio-One Ltd shared £3,000,000,000 8 Mar 2021 active
Greiner Bio-One Ltd shared · · active
Grifols UK Ltd shared £3,000,000,000 8 Mar 2021 active
Grifols UK Ltd shared · · active
Healthlinked Ltd shared £3,000,000,000 8 Mar 2021 active
Healthlinked Ltd shared · · active
Hologic Limited shared £3,000,000,000 8 Mar 2021 active
Hologic Limited shared · · active
HORIBA UK Limited shared £3,000,000,000 8 Mar 2021 active
HORIBA UK LImited shared · · active
Hymon International (UK) Ltd shared £3,000,000,000 8 Mar 2021 active
Hymon International UK Ltd shared · · active
IDvet shared £3,000,000,000 8 Mar 2021 active
IDvet shared · · active
Illumina Cambridge Ltd shared £3,000,000,000 8 Mar 2021 active
Illumina Cambridge Ltd shared · · active
Immensa Health Clinic Ltd shared £3,000,000,000 8 Mar 2021 active
Immensa Health Clinic Ltd shared · · active
Intertek Testing & Certification Limited shared £3,000,000,000 8 Mar 2021 active
Intertek Testing & Certification Limited shared · · active
Invitech Limited shared · · active
Invitech Ltd shared £3,000,000,000 8 Mar 2021 active
LabMediaServis s.r.o. shared £3,000,000,000 8 Mar 2021 active
LabMediaServis s.r.o. shared · · active
Launch Diagnostics Ltd shared £3,000,000,000 8 Mar 2021 active
Launch Diagnostics Ltd shared · · active
Life Technologies Limited shared £3,000,000,000 8 Mar 2021 active
Life Technologies Limited shared · · active
Luminex Corporation shared £3,000,000,000 8 Mar 2021 active
Luminex Corporation shared · · active
LumiraDx Ltd shared £3,000,000,000 8 Mar 2021 active
LumiraDx UK Ltd shared · · active
Malvern Medical Developments Ltd shared £3,000,000,000 8 Mar 2021 active
Malvern Medical Developments Ltd shared · · active
Mast Group Ltd shared £3,000,000,000 8 Mar 2021 active
Mast Group Ltd shared · · active
Medical Wire & Equipment Co (Bath) Ltd shared £3,000,000,000 8 Mar 2021 active
Medical Wire & Equipment Co. (Bath) Ltd shared · · active
Medline Scientific Limited shared £3,000,000,000 8 Mar 2021 active
Medline Scientific Limited shared · · active
Medusa19 Healthcare Limited shared £3,000,000,000 8 Mar 2021 active
Medusa19 Healthcare Limited shared · · active
MGI International Sales Co. Ltd shared £3,000,000,000 8 Mar 2021 active
MGI International Sales Co. Ltd shared · · active
Microgen Bioproducts Ltd shared £3,000,000,000 8 Mar 2021 active
Microgen Bioproducts Ltd shared · · active
Mobidiag UK Ltd shared £3,000,000,000 8 Mar 2021 active
Mobidiag UK Ltd shared · · active
Mornington 2000 LLP trading as Sterilab Services shared £3,000,000,000 8 Mar 2021 active
Mornington 2000LLP trading as Sterilab Services shared · · active
MultiplexDX, s.r.o. shared £3,000,000,000 8 Mar 2021 active
MultiplexDX, s.r.o. shared · · active
nal von minden GmbH shared £3,000,000,000 8 Mar 2021 active
nal von minden GmbH shared · · active
OptiGene Limited shared £3,000,000,000 8 Mar 2021 active
OptiGene Limited shared · · active
Origin Packaging Ltd shared £3,000,000,000 8 Mar 2021 active
Origin Packaging Ltd shared · · active
Ortho Clinical Diagnostics shared £3,000,000,000 8 Mar 2021 active
Ortho Clinical Diagnostics shared · · active
OscarTech UK Ltd shared £3,000,000,000 8 Mar 2021 active
OscarTech UK Ltd shared · · active
Oxford Biosystems Ltd shared £3,000,000,000 8 Mar 2021 active
Oxford Biosystems Ltd shared · · active
Oxford Immunotec Ltd shared £3,000,000,000 8 Mar 2021 active
Oxford Immunotec Ltd shared · · active
Oxford Nanopore Diagnostics Limited shared · · active
Oxford Nanopore Diagnostics Ltd shared £3,000,000,000 8 Mar 2021 active
Pathway Diagnostics Ltd shared £3,000,000,000 8 Mar 2021 active
Pathway Diagnostics Ltd shared · · active
PerkinElmer LAS (UK) Limited shared £3,000,000,000 8 Mar 2021 active
PerkinElmer LAS (UK) Limited shared · · active
Primer Design Ltd shared £3,000,000,000 8 Mar 2021 active
Primer Design Ltd shared · · active
Pro-Lab Diagnostics shared £3,000,000,000 8 Mar 2021 active
Pro-Lab Diagnostics shared · · active
Promega UK Ltd shared £3,000,000,000 8 Mar 2021 active
Promega UK Ltd shared · · active
Qiagen Ltd shared £3,000,000,000 8 Mar 2021 active
Qiagen Ltd shared · · active
QuantuMDx Group Limited shared £3,000,000,000 8 Mar 2021 active
QuantuMDx Group Limited shared · · active
Quidel Ireland Ltd shared £3,000,000,000 8 Mar 2021 active
Quidel Ireland Ltd shared · · active
Randox Laboratories Ltd shared £3,000,000,000 8 Mar 2021 active
Randox Laboratories Ltd shared · · active
Rapid Labs Ltd shared £3,000,000,000 8 Mar 2021 active
Rapid Labs Ltd shared · · active
R-Biopharm Rhone Ltd shared £3,000,000,000 8 Mar 2021 active
R-Biopharm Rhone Ltd shared · · active
Roche Diagnostics Limited shared £3,000,000,000 8 Mar 2021 active
Roche Diagnostics Limited shared · · active
RTA Laboratuvarlari shared £3,000,000,000 8 Mar 2021 active
RTA Laboratuvarlari shared · · active
Scientific Laboratory Supplies Ltd shared £3,000,000,000 8 Mar 2021 active
Scientific Laboratory Supplies Ltd shared · · active
SeraCare Life Sciences, Inc., dba LGC Clinical Diagnostics shared £3,000,000,000 8 Mar 2021 active
SeraCare Life Sciences, Inc., dba LGC Clinical Diagnostics shared · · active
Serosep UK Limited shared £3,000,000,000 8 Mar 2021 active
Serosep UK Limited shared · · active
Siemens Healthcare Diagnostics Limited shared £3,000,000,000 8 Mar 2021 active
Siemens Healthcare Diagnostics Limited shared · · active
SpeeDx Ltd shared £3,000,000,000 8 Mar 2021 active
SpeeDx Ltd shared · · active
SPT Labtech Ltd shared £3,000,000,000 8 Mar 2021 active
SPT Labtech Ltd shared · · active
Sterilin Limited shared £3,000,000,000 8 Mar 2021 active
Stratech Scientific Ltd shared £3,000,000,000 8 Mar 2021 active
Stratech Scientific Ltd shared · · active
SureScreen Diagnostics Ltd shared £3,000,000,000 8 Mar 2021 active
SureScreen Diagnostics Ltd shared · · active
Sysmex UK Ltd shared £3,000,000,000 8 Mar 2021 active
Sysmex UK Ltd shared · · active
Tanner Pharma UK Limited shared £3,000,000,000 8 Mar 2021 active
Tanner Pharma UK Limited shared · · active
Tecan UK shared £3,000,000,000 8 Mar 2021 active
Tecan UK shared · · active
Technopath Distribution Limited shared £3,000,000,000 8 Mar 2021 active
Techno-path Distribution Ltd shared · · active
Teva UK Ltd shared £3,000,000,000 8 Mar 2021 active
Teva UK Ltd shared · · active
The Binding Site Group Limited shared £3,000,000,000 8 Mar 2021 active
The Binding Site Group Limited shared · · active
Thermo Fisher Diagnostics Ltd shared £3,000,000,000 8 Mar 2021 active
Thermo Fisher Diagnostics Ltd shared · · active
Thermofisher Scientific T/A Sterilin Ltd shared · · active
TMC Worldnetwork Ltd shared £3,000,000,000 8 Mar 2021 active
TMC Worldnetwork Ltd shared · · active
UKOS Ltd shared £3,000,000,000 8 Mar 2021 active
UKOS Ltd shared · · active
Una Health Ltd shared £3,000,000,000 8 Mar 2021 active
Una Health Ltd shared · · active
Vectornate UK Ltd shared £3,000,000,000 8 Mar 2021 active
Vectornate UK Ltd shared · · active
V. H. Bio Limited shared £3,000,000,000 8 Mar 2021 active
V. H. Bio Limited shared · · active
VWR International Ltd shared £3,000,000,000 8 Mar 2021 active
VWR International Ltd shared · · active
Werfen Ltd shared £3,000,000,000 8 Mar 2021 active
Werfen Ltd shared · · active
Wolf Laboratories Limited shared £3,000,000,000 8 Mar 2021 active
Wolf Laboratories Limited shared · · active
Wuhan HealthCare Biotechnology Co., Ltd shared · · active
Wuhan HealthCare Biotechnology Co., Ltd. shared £3,000,000,000 8 Mar 2021 active
Yourgene Health UK Ltd shared £3,000,000,000 8 Mar 2021 active
Yourgene Health UK Ltd shared · · active

description

Lot 1 - Diagnostic Goods and Services is for the supply of in vitro diagnostic medical devices and associated services including equipment, consumables, maintenance, and peripheral equipment and associated services. All reagents and consumables comply with current CE regulations (UKCA regulations when applicable) and must retain the CE mark (or, once superseded, the UKCA mark) for the duration of the Framework and any potential extensions. This Lot includes provisions for reagent rental and managed equipment services.

Please note that this Award Notice is for Lot 1, however the Framework Agreement encompasses the following four lots:

  • Lot 1: Diagnostic Goods and Services
  • Lot 2: Research and Development Goods and Services
  • Lot 3: Manufacturing, Product Development and Commercialisation
  • Lot 4: Clinical Laboratory Diagnostic Testing Services

Additional information:

The term of the framework is for an initial 2 years with options to extend by up to a further 2 years.

The value attributed to each Lot is an approximate estimate only, the actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements.

The scope of this Framework Agreement covers Goods and Services that are subject to rapid and frequent improvements, advancements and new scientific and technical developments. Therefore, to keep this Framework Agreement in line with the latest market and scientific developments so as to ensure that patients and other end users have ongoing access to state of the art diagnostics for the duration of this Framework Agreement successful Suppliers will be able to propose new and/or updated Goods and/or Services to be added to a Supplier's range under the Framework Agreement if one or more of the following circumstances apply:

  • Where the proposed updated Goods or Services fall within the general scope of this procurement as set out as part of this OJEU Contract Notice (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the description sections of this Contract Notice);
  • Where the proposed new Goods or Services fall within the broad categories of Goods or Services covered by this Framework Agreement (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice), but are new to the market. For the avoidance of doubt, for the purposes of any testing services, this will allow Suppliers to offer new types of tests, new test kits, related new equipment / products, related new consumables and related new Services as and when they become available during the duration of the Framework Agreement provided they fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice);
  • Where the proposed new or updated Goods or Services reflect a product or service line extension (i.e. are new, modified or updated products or services in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement); or
  • Where the proposed new or updated Goods or Services reflect a range extension (i.e. are new, modified or updated products or services that reflect an expansion of the Supplier's range in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement).

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
16 Apr 2021 Contract award notice (F03) Earlier regulations 008137-2021
19 Apr 2021 Award (award) · c87ea5c3-e23f-4432-9bc1-996a39f1cc48-429569

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.